2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 35.288 | 28.629 | 39.751 | 55.773 | 71.404 | 96.270 | 140.211 | 160.238 | 150.490 | 926.164 |
Total Income - EUR | 35.424 | 28.660 | 39.811 | 56.903 | 71.989 | 96.503 | 140.331 | 160.597 | 152.186 | 926.904 |
Total Expenses - EUR | 33.822 | 28.336 | 35.805 | 40.073 | 69.948 | 83.176 | 126.730 | 143.079 | 125.484 | 857.793 |
Gross Profit/Loss - EUR | 1.602 | 324 | 4.007 | 16.829 | 2.041 | 13.326 | 13.601 | 17.517 | 26.703 | 69.111 |
Net Profit/Loss - EUR | 540 | -249 | 3.609 | 16.260 | 1.325 | 12.425 | 12.278 | 15.992 | 25.257 | 49.432 |
Employees | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Cosflorimal S.r.l.
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 4.953 | 1.442 | 0 | 21.134 | 17.183 | 9.985 | 4.322 | 0 | 9.526 | 195.060 |
Current Assets | 25.589 | 18.873 | 23.252 | 20.782 | 27.253 | 52.800 | 66.524 | 77.792 | 89.790 | 269.369 |
Inventories | 0 | 0 | 102 | 100 | 112 | 110 | 82 | 2.446 | 5.084 | 11.003 |
Receivables | 14.652 | 12.733 | 4.512 | 3.565 | 11.230 | 31.884 | 32.908 | 29.516 | 51.768 | 130.156 |
Cash | 10.936 | 6.140 | 18.638 | 17.117 | 15.911 | 20.806 | 33.533 | 45.829 | 32.939 | 128.210 |
Shareholders Funds | -50.863 | -50.593 | -46.129 | -29.022 | -27.134 | -14.194 | -1.601 | 14.385 | 39.598 | 245.306 |
Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 200 |
Debts | 81.404 | 70.908 | 69.380 | 70.937 | 71.570 | 76.980 | 72.447 | 63.406 | 59.718 | 219.123 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 1 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
Main CAEN | "4941 - 4941" | |||||||||
CAEN Financial Year |
4941
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Cosflorimal S.r.l.